Sep 5, 2025 09:33AM
Jun 27, 2025 07:00AM
Jun 25, 2025 08:03AM
Jun 25, 2025 08:00AM
Oct 26, 2023 07:15PM
Oct 24, 2023 04:41PM
Oct 24, 2023 04:38PM InMed Pharmaceuticals Announces $5.2 Million Private Placement and Preferred Investment Option Exercise Priced At-the-Market under Nasdaq Rules
Sep 7, 2023 08:30AM
Nov 21, 2022 05:00PM
Nov 18, 2022 08:01AM
Nov 18, 2022 08:00AM
Sep 13, 2022 05:12PM
Sep 12, 2022 05:29AM
Sep 9, 2022 05:00PM InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
Jun 6, 2022 06:49PM
Jun 2, 2022 08:02AM
Jun 2, 2022 08:00AM
Apr 19, 2022 07:30AM
Nov 29, 2021 06:30AM
Nov 10, 2021 07:30AM
Nov 10, 2021 07:30AM InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update
Sep 24, 2021 07:30AM
Sep 24, 2021 07:30AM
Sep 9, 2021 07:18PM
Sep 9, 2021 07:18PM
Aug 12, 2021 12:00PM
Aug 12, 2021 12:00PM
Jul 2, 2021 04:15PM InMed Pharmaceuticals Announces Closing of US$12 Million Private Placement Priced At-the-Market under Nasdaq Rules
Jul 2, 2021 04:15PM
Jun 29, 2021 07:05AM
Jun 29, 2021 07:04AM
Jun 29, 2021 07:00AM
Jun 29, 2021 07:00AM
Mar 3, 2021 06:00PM
Jan 5, 2021 04:52PM InMed to Participate at Virtual Conferences in January 2021

20,596 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All